Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study 934: TDF+FTC+EFV vs Combivir+EFV in HIV-1
NCT00112047Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate, emtricitabine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Jul 2003; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00112047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112047.